475830 Stock Chart & Stats
₩45500.00
-₩2,200.00(-4.61%)
―
--
Day’s Range― - ―
52-Week Range₩20,500.00 - ₩146,600.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)191.15K
Market Cap
₩988.24B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.52
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding21,719,590
10 Day Avg. Volume84,081
30 Day Avg. Volume191,150
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)2,431,718.06
Revenue Forecast (FY)₩10.00T>
475830 FAQ
What was Orum Therapeutics, Inc.’s price range in the past 12 months?
Orum Therapeutics, Inc. lowest stock price was ₩20500.00 and its highest was ₩146600.00 in the past 12 months.
What is Orum Therapeutics, Inc.’s market cap?
Orum Therapeutics, Inc.’s market cap is ₩988.24B.
When is Orum Therapeutics, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Orum Therapeutics, Inc.’s earnings last quarter?
Currently, no data Available
Is Orum Therapeutics, Inc. overvalued?
According to Wall Street analysts Orum Therapeutics, Inc.’s price is currently Undervalued.
Does Orum Therapeutics, Inc. pay dividends?
Orum Therapeutics, Inc. does not currently pay dividends.
What is Orum Therapeutics, Inc.’s EPS estimate?
Orum Therapeutics, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Orum Therapeutics, Inc. have?
Orum Therapeutics, Inc. has 21,719,590 shares outstanding.
What happened to Orum Therapeutics, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Orum Therapeutics, Inc.?
Currently, no hedge funds are holding shares in KR:475830
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Daewoong Co., Ltd.
―
CHA Biotech Co., Ltd.
―
DongKook Pharmaceutical Co., Ltd.
―
Chong Kun Dang Pharmaceutical Corp.
―
HK inno.N Corporation
―